Waters (WAT) Competitors $374.24 -6.57 (-1.73%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$374.56 +0.32 (+0.09%) As of 02/21/2025 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends WAT vs. A, MTD, ILMN, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMOShould you be buying Waters stock or one of its competitors? The main competitors of Waters include Agilent Technologies (A), Mettler-Toledo International (MTD), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Waters vs. Agilent Technologies Mettler-Toledo International Illumina Bio-Techne Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Waters (NYSE:WAT) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, media sentiment, risk, profitability, dividends, community ranking and earnings. Which has more volatility and risk, WAT or A? Waters has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Do analysts prefer WAT or A? Waters currently has a consensus price target of $390.40, indicating a potential upside of 4.32%. Agilent Technologies has a consensus price target of $144.38, indicating a potential upside of 6.69%. Given Agilent Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Agilent Technologies is more favorable than Waters.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Waters 0 Sell rating(s) 10 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.44Agilent Technologies 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media prefer WAT or A? In the previous week, Waters had 24 more articles in the media than Agilent Technologies. MarketBeat recorded 44 mentions for Waters and 20 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 1.25 beat Waters' score of 0.22 indicating that Agilent Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waters 14 Very Positive mention(s) 3 Positive mention(s) 14 Neutral mention(s) 2 Negative mention(s) 6 Very Negative mention(s) Neutral Agilent Technologies 14 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings and valuation, WAT or A? Agilent Technologies has higher revenue and earnings than Waters. Agilent Technologies is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWaters$2.96B7.51$637.83M$10.7134.94Agilent Technologies$6.51B5.93$1.29B$4.4230.62 Do institutionals and insiders believe in WAT or A? 94.0% of Waters shares are owned by institutional investors. Comparatively, 87.4% of Agilent Technologies shares are owned by institutional investors. 0.8% of Waters shares are owned by insiders. Comparatively, 0.3% of Agilent Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is WAT or A more profitable? Waters has a net margin of 21.56% compared to Agilent Technologies' net margin of 19.80%. Waters' return on equity of 46.31% beat Agilent Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Waters21.56% 46.31% 15.67% Agilent Technologies 19.80%25.43%13.79% Does the MarketBeat Community prefer WAT or A? Agilent Technologies received 426 more outperform votes than Waters when rated by MarketBeat users. Likewise, 71.05% of users gave Agilent Technologies an outperform vote while only 53.41% of users gave Waters an outperform vote. CompanyUnderperformOutperformWatersOutperform Votes43853.41% Underperform Votes38246.59% Agilent TechnologiesOutperform Votes86471.05% Underperform Votes35228.95% SummaryWaters beats Agilent Technologies on 10 of the 19 factors compared between the two stocks. Get Waters News Delivered to You Automatically Sign up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WAT vs. The Competition Export to ExcelMetricWatersAnalytical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$22.22B$5.06B$5.80B$20.03BDividend YieldN/A0.45%4.78%3.65%P/E Ratio34.9425.8126.4534.88Price / Sales7.513.88450.0615.60Price / Cash24.9937.2944.0420.85Price / Book12.152.007.634.92Net Income$637.83M-$83.57M$3.18B$1.02B7 Day Performance1.23%-2.41%-1.85%-1.05%1 Month Performance-9.52%-7.72%0.19%-1.39%1 Year Performance13.58%-22.00%17.21%13.93% Waters Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WATWaters3.9948 of 5 stars$374.24-1.7%$390.40+4.3%+13.6%$22.22B$2.96B34.947,900AAgilent Technologies4.3532 of 5 stars$134.57-1.4%$144.38+7.3%0.0%$38.39B$6.51B30.4517,900Upcoming EarningsDividend AnnouncementPositive NewsMTDMettler-Toledo International3.9244 of 5 stars$1,273.44-1.8%$1,368.00+7.4%+7.7%$26.64B$3.87B31.4217,300Positive NewsILMNIllumina4.7685 of 5 stars$100.24-1.5%$159.45+59.1%-30.9%$15.90B$4.37B-13.059,300TECHBio-Techne4.9274 of 5 stars$65.94-1.2%$86.57+31.3%-9.5%$10.48B$1.16B66.613,100Analyst DowngradeInsider TradeCRLCharles River Laboratories International4.8258 of 5 stars$152.07-0.7%$200.79+32.0%-32.3%$7.78B$4.13B19.0321,800Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews CoverageBIOBio-Rad Laboratories4.7626 of 5 stars$276.55-9.7%$395.20+42.9%-17.5%$7.74B$2.57B-10.128,030High Trading VolumeBRKRBruker4.8541 of 5 stars$50.04-2.2%$70.50+40.9%-38.0%$7.59B$2.96B24.069,707PACBPacific Biosciences of California2.2986 of 5 stars$1.85+25.0%$2.85+54.3%-69.7%$506.64M$200.52M-1.27730Analyst ForecastOptions VolumeAnalyst RevisionNews CoverageGap UpHigh Trading VolumeHBIOHarvard Bioscience2.2163 of 5 stars$1.35+1.5%N/A-77.7%$58.89M$112.25M-4.09490Gap DownTMOThermo Fisher Scientific4.7358 of 5 stars$532.580.0%$658.00+23.5%-3.7%$203.71B$42.88B32.22122,000Dividend IncreaseAnalyst RevisionPositive News Related Companies and Tools Related Companies A Competitors MTD Competitors ILMN Competitors TECH Competitors CRL Competitors BIO Competitors BRKR Competitors PACB Competitors HBIO Competitors TMO Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:WAT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Waters Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Waters With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WAT Stock Alerts